Mike
Schmitkamp
,
Walter
Leitner
and
Giancarlo
Franciò
*
Institut für Technische und Makromolekulare Chemie, RWTH Aachen University, Worringerweg 1, 52074 Aachen, Germany. E-mail: francio@itmc.rwth-aachen.de; Fax: +49-241-80 22177; Tel: +49-241-80 26492
First published on 1st November 2012
Phosphoramidite and P-stereogenic phosphorodiamidite ligands derived from (Sa)-2-phenylamino-2′-hydroxy-1,1′-binaphthyl (N-Ph-NOBIN) and bis(1-phenyl-ethyl)amine were synthesised, fully characterised, and the absolute configuration of the stereogenic phosphorus atoms was assigned. The phosphoramidite ligand L2 features three non-bridged substituents at phosphorus comprising the bis(1-phenylethyl)amine and two NOBIN moieties. The NOBIN units are bound to the phosphorus through the oxygen atoms with two pendant nitrogen atoms. In the Ni-catalysed hydrovinylation of styrene no conversion was observed with the phosphorodiamidites, while the phosphoramidite ligands led to active catalysts with a marked co-operative effect on selectivities. Whereas the racemic product was obtained with the (Sa,Sa,SC,SC) diastereomer, the (Sa,Sa,RC,RC) diastereomer proved to be one of the best ligands for this reaction, leading to almost perfect selectivity and ees of up to 91%.
![]() | ||
| Fig. 1 Phosphoramidite, phosphorous triamide and phosphorodiamidite with related structures. | ||
Despite the close similarity of the atropoisomeric amino-alcohol NOBIN (NOBIN = 2′-amino-1,1′-binaphthyl-2-ol)10 to BINOL, no corresponding phosphorodiamidite ligands have been reported yet.11 Intrigued by this structural variation, we set to synthesise phosphorodiamidite ligands from the NOBIN moiety and the bis(1-phenylethyl)amine, a very successful chiral synthon for phosphoramidite ligands.12,13
We describe here the synthesis of P-stereogenic phosphorodiamidite derived from (Sa)-2′-(phenylamino)-1,1′-binaphthyl-2-ol and both enantiomers of bis(1-phenylethyl)amine. In addition to the expected phosphorodiamidite of structure A, the non-cyclic phosphoramidite structure B (Fig. 1) could be obtained in excellent yields and proved the preferred arrangement in asymmetric hydrovinylation.
![]() | ||
| Scheme 1 Phosphorodiamidite synthesis. | ||
The assignment of the absolute configuration of the stereogenic phosphorus atom16 was accomplished by computational methods and corroborated by NMR spectroscopy. The conformational minima for both diastereomeric pairs were calculated via conformational searches at the PM3 level followed by geometry optimisation through DFT calculation (see ESI†). The calculation showed that for both phosphorodiamidites (Sa,SC,SC)-L1 and (Sa,RC,RC)-L1 the R configuration at the phosphorus is strongly favoured with a ΔG of 8.7 and 5.2 kcal mol−1 for the pairs (Sa,SC,SC,RP)–(Sa,SC,SC,SP) and (Sa,RC,RC,RP)–(Sa,RC,RC,SP), respectively. These findings were confirmed in solution by 2D NOE experiments, where predicted interactions specific for RP-diastereomers were actually found (see ESI†).
The minor products isolated in 12–13% yield from the reactions described above showed in the 31P{1H}-NMR-spectra a singlet at δ = 141.17 and 141.37 ppm for the compound obtained from (Sa)-N-Ph-NOBIN with (SC,SC)-1 and (RC,RC)-1, respectively. 1H and 13C NMR spectroscopy as well as mass analysis revealed these compounds as phosphoramidites of type B comprising a bis(1-phenyl-ethyl)amine and two (Sa)-N-Ph-NOBIN moieties, which are bound to the phosphorus through the oxygen atoms. The latter connectivity could be unequivocally confirmed on the basis of 13C NMR: the quaternary carbons next to the oxygen atoms appear as doublets at δ = 150.59 (J13C–31P = 6.3 Hz) and 150.43 (J13C–31P = 7.6 Hz) ppm for (Sa,Sa,SC,SC)-L2 and at δ = 150.84 (J13C–31P = 8.6 Hz) and 150.30 (J13C–31P = 1.8 Hz) ppm for (Sa,Sa,RC,RC)-L2, respectively, as the most downfield signals. In contrast, in both diastereomers the quaternary carbon next to the nitrogen atoms does not show any phosphorus-coupling.
Based on this unexpected observation, the reaction conditions were adjusted in order to favour the formation of type B structures. Thus, the synthesis was carried out using a (Sa)-N-Ph-NOBIN/1 molar ratio of 2
:
1, the addition sequence inverted (i.e. the PCl2-compound 1 was added to NOBIN), and the concentration increased by a factor of 10 to facilitate the inter- over the intra-molecular addition (Scheme 2). Indeed, phosphoramidites (Sa,Sa,SC,SC)- and (Sa,Sa,RC,RC)-L2 formed as the only P-containing species and could be isolated in 69% and 70% yields, respectively.
![]() | ||
| Scheme 2 Phosphoramidite synthesis. | ||
![]() | ||
| Scheme 3 Hydrovinylation of styrene. | ||
Both (Sa,RC,RC,RP)-L1 and (Sa,SC,SC,RP)-L1 did not form an active Ni-catalyst (Table 1, entries 1 and 2). This result is surprising as the structure of the phosphorodiamidites L1 lies “in-between” that of the Feringa phosphoramidite and that of the phosphorous triamides based on the 2,2′-diamino-1,1′-binaphthyl backbone, which led to high conversions and enantioselectivities of 91% and 40% ee, respectively, under similar reaction conditions.8,18a
| Entry | Ligand | 2/[Ni] | T (°C) | t (h) | Conversion (%) | Selectivitya (%) | ee (%) | ||
|---|---|---|---|---|---|---|---|---|---|
| 3 | 4 | Olig. | |||||||
| a Selectivity refers to products of styrene.19 | |||||||||
| 1 | (Sa,SC,SC,RP)-L1 | 500 | 20 | 1 | 4 | — | — | — | — |
| 2 | (Sa,RC,RC,RP)-L1 | 500 | 20 | 1 | 4 | — | — | — | — |
| 3 | (Sa,Sa,SC,SC)-L2 | 500 | 20 | 1 | 92 | 66 | 2 | 32 | rac |
| 4 | (Sa,Sa,RC,RC)-L2 | 500 | 20 | 1 | >99 | 34 | 11 | 54 | 74(S) |
| 5 | (Sa,Sa,RC,RC)-L2 | 200 | −20 | 2.5 | >99 | 85 | 2 | 13 | 88(S) |
| 6 | (Sa,Sa,RC,RC)-L2 | 200 | −30 | 2.5 | 96 | 99 | — | 1 | 91(S) |
Most intriguingly, the use of the phosphoramidite (Sa,Sa,SC,SC)-L2 resulted in an active but unselective hydrovinylation catalyst and the target chiral product 3-phenyl-but-1-ene 3 was obtained as a racemic mixture (entry 3). The other diastereomer (Sa,Sa,RC,RC)-L2 was more active as judged from the considerable amounts of products from the consecutive isomerisation and oligomerisation reactions (entry 4). More importantly, product 3 was obtained with an enantioselectivity of 74% (S) ee. Lowering the reaction temperature to −20 °C, both selectivity and ee could be improved to 85% and 88%, respectively (entry 5). Finally, carrying out the hydrovinylation at −30 °C (entry 6), the consecutive reactions could be suppressed and 3-phenyl-but-1-ene was obtained with almost perfect selectivity19 and an ee of 91% (S). This enantioselectivity value is at the same level as that achieved with benchmark catalytic systems under comparable conditions, while the catalyst activity (TOFav of 80 h−1) is circa one order of magnitude lower. Noticeably, the new catalytic system allowed high selectivity towards 3 also at very high styrene conversion (entry 6) indicating that it is less prone to promote the isomerisation and other consecutive reactions in comparison to BINOL-based phosphoramidites.18a
![]() | ||
| Fig. 2 Synthesis of phosphoramidites vs. phosphorodiamidite ligands. | ||
All chiral phosphoramidites successfully applied in catalysis today are based on a diol and a monoamine,3,20 and the presence of a cyclic unit is believed to ensure high stability as a necessity to impart a definite stereo-arrangement to the resulting ligand.3 In this respect, (Sa,Sa,RC,RC)-L2, composed of two (amino)alcohol moieties and a monoamine, is unique and is the first phosphoramidite of this type leading to a highly enantioselective catalytic transformation. The striking difference in the enantioselectivity obtained with two diastereomers of L2 shows once again the importance of cooperative effects between the various chiral elements within the ligand structure.21 An intervention of the free NH functionalities during the catalytic cycle cannot be excluded at this stage.
:
n-pentane = 2
:
5; (Sa,SC,SC,RP)-L1: Rf = 0.79, (Sa,Sa,SC,SC)-L2: Rf = 0.61). Yield: (Sa,SC,SC,RP)-L1 = 194 mg (45%); (Sa,Sa,SC,SC)-L2 = 83 mg (12%).
1H-NMR (600 MHz, CDCl3): δ = 8.04 (d, 1H, J = 8.8 Hz, Ar), 7.97 (d, 1H, J = 8.2 Hz, Ar), 7.90 (d, 1H, J = 7.9 Hz, Ar), 7.81 (d, 1H, J = 8.8 Hz, Ar), 7.68 (d, 1H, J = 8.8 Hz, Ar), 7.54 (d, 1H, J = 8.8 Hz, Ar), 7.51 (m, 1H, Ar), 7.48–7.42 (m, 3H, Ar), 7.39–7.31 (m, 8H, Ar), 7.28–7.22 (m, 4H, Ar), 6.85–6.76 (m, 3H, Ar), 6.22 (d, 2H, J = 7.9 Hz, Ar), 4.54 (m, 2H, CHCH3), 1.84 (d, 6H, J = 7.0 Hz, CH3) ppm. 13C{1H}-NMR (150 MHz, CDCl3): δ = 150.60 (Cq), 148.20 (d, J = 26.2 Hz, Cq), 143.10 (d, J = 1.4 Hz, 2Cq), 141.84 (d, J = 5.4 Hz, Cq), 133.12 (d, J = 2.4 Hz, Cq), 132.83 (Cq), 131.83 (Cq), 131.32 (Cq), 130.37 (CH), 129.88 (Cq), 129.59 (CH), 128.92 (2CH), 128.90 (2CH), 128.60 (d, J = 1.4 Hz, 2CH), 128.51 (CH), 128.11 (2CH), 128.05 (CH), 128.03 (4CH), 127.14 (2CH), 126.55 (CH), 126.21 (CH), 126.06 (CH), 125.84 (d, J = 5.5 Hz, Cq), 125.45 (CH), 124.59 (CH), 122.52 (d, J = 2.3 Hz, CH), 121.42 (CH), 121.07 (d, J = 12.7 Hz, 2CH), 54.21 (CHCH3), 54.14 (CHCH3), 21.85 (2CHCH3) ppm. 31P{1H}-NMR (243 MHz, CDCl3): δ = 142.72. HRMS (ESI): m/z = calcd for C68H54N3O2P: 614.24815; found: 614.24627; [α]20D = −258° (c = 0.1, CH2Cl2).
:
n-pentane = 2
:
5; (Sa,RC,RC,RP)-L1: Rf = 0.75, (Sa,Sa,RC,RC)-L2: Rf = 0.64). Yield: (Sa,RC,RC,RP)-L1 = 151 mg (35%); (Sa,Sa,RC,RC)-L2 = 90 mg (13%).
1H-NMR (600 MHz, CDCl3): δ = 7.96–7.93 (m, 3H, Ar), 7.92 (d, 1H, J = 8.1 Hz, Ar), 7.62 (d, 1H, J = 8.8 Hz, Ar), 7.51–7.44 (m, 4H, Ar), 7.35–7.28 (m, 3H, Ar), 7.20–7.12 (m, 12H, Ar), 7.08 (d, 2H, J = 8.1 Hz, Ar), 6.94 (7, 1H, J = 7.3 Hz, Ar), 4.60 (m, 2H, CHCH3), 1.93 (d, 6H, J = 7.0 Hz, CH3) ppm. 13C{1H}-NMR (150 MHz, CDCl3): δ = 149.89 (Cq), 148.44 (d, J = 26.0 Hz, Cq), 142.73 (b, 2Cq), 141.62 (d, J = 4.2 Hz, Cq), 132.93 (d, J = 2.2 Hz, Cq), 132.74 (Cq), 131.85 (Cq), 131.22 (d, J = 1.2 Hz, Cq), 130.32 (Cq), 130.15 (CH), 129.36 (CH), 128.76 (d, J = 1.3 Hz, 2CH), 128.47 (CH), 128.24 (4CH), 128.05 (CH), 127.97 (CH), 127.76 (CH), 127.67 (4CH), 126.58 (2CH), 126.37 (CH), 126.08 (CH), 126.03 (CH), 125.77 (d, J = 5.5 Hz, Cq), 125.50 (CH), 124.45 (CH), 122.20 (d, J = 2.3 Hz, CH), 121.78 (CH), 121.18 (d, J = 13.2 Hz, 2CH), 54.12 (CHCH3), 54.05 (CHCH3), 22.15 (2CHCH3) ppm. 31P{1H}-NMR (243 MHz, CDCl3): δ = 135.00. HRMS (ESI): m/z = calcd for C68H54N3O2P: 614.24815; found: 614.24792; [α]20D = 579° (c = 0.1, CH2Cl2).
:
n-pentane = 2
:
5; (Sa,Sa,SC,SC)-L2: Rf = 0.61). Yield = 198 mg (69%).
1H-NMR (600 MHz, CDCl3): δ = 7.99 (d, 1H, J = 8.0 Hz, Ar), 7.93 (d, 1H, J = 9.1 Hz, Ar), 7.90 (d, 1H, J = 8.9 Hz, Ar), 7.89 (d, 1H, J = 7.9 Hz, Ar), 7.86 (d, 1H, J = 8.3 Hz, Ar), 7.81 (d, 1H, J = 9.0 Hz, Ar), 7.71 (d, 1H, J = 9.0 Hz, Ar), 7.69 (d, 1H, J = 8.3 Hz, Ar), 7.49 (m, 1H, Ar), 7.44 (m, 1H, Ar), 7.38–7.29 (m, 7H, Ar), 7.27–7.23 (m, 5H, Ar), 7.22–7.17 (m, 2H, Ar), 7.10–7.05 (m, 7H, Ar), 7.03 (d, 1H, J = 8.5 Hz, Ar), 6.98 (t, 1H, J = 7.4 Hz, Ar), 6.92 (t, 2H, J = 7.9 Hz, Ar), 6.72 (t, 1H, J = 7.4 Hz, Ar), 6.67 (d, 2H, J = 7.7 Hz, Ar), 6.65–6.59 (m, 4H, Ar), 6.48 (d, 1H, J = 8.9 Hz, Ar), 6.17 (d, 1H, J = 9.0 Hz, Ar), 5.61 (s, 1H, OH), 5.55 (s, 1H, OH), 4.31 (s br, 2H, CHCH3), 0.87 (d, 6H, J = 8.0 Hz, CH3) ppm. 13C{1H}-NMR (150 MHz, CDCl3): δ = 150.59 (d, J = 6.3 Hz, Cq), 150.43 (d, J = 7.6 Hz, Cq), 143.07 (Cq), 142.91 (Cq), 142.63 (2Cq), 139.83 (Cq), 139.61 (Cq), 134.95 (Cq), 134.82 (Cq), 134.24 (Cq), 133.61 (Cq), 130.53 (Cq), 130.08 (Cq), 129.72 (Cq), 129.54 (Cq), 129.46 (CH), 129.39 (CH), 129.32 (2CH), 128.94 (2CH), 128.90 (CH), 128.75 (CH), 128.35 (4CH), 128.29 (CH), 128.14 (2CH), 127.95 (CH), 127.77 (4CH), 126.84 (CH), 126.81 (2CH), 126.44 (2CH), 126.43 (CH), 125.81 (2CH), 125.65 (CH), 125.42 (CH), 124.48 (2CH), 123.43 (CH), 123.17 (CH), 121.67 (CH), 121.60 (d, J = 2.9 Hz, Cq), 121.02 (d, J = 2.6 Hz, Cq), 120.95 (CH), 120.56 (d, J = 11.6 Hz, CH), 119.91 (d, J = 17.5 Hz, CH), 119.54 (2CH), 119.32 (CH), 118.99 (Cq), 118.32 (2CH), 118.30 (Cq), 117.90 (CH), 51.81 (CHCH3), 51.74 (CHCH3), 20.67 (2CHCH3) ppm. 31P{1H}-NMR (243 MHz, CDCl3): δ = 141.17. HRMS (ESI): m/z = calcd for C68H54N3O2P: 975.39482; found: 975.39520; [α]20D = 173° (c = 0.1, CH2Cl2).
:
n-pentane = 2:1); yield: = 199 mg (70%).
1H-NMR (600 MHz, CDCl3): δ = 7.96 (d, 1H, J = 9.0 Hz, Ar), 7.93–7.89 (m, 3H, Ar), 7.85 (d, 1H, J = 8.0 Hz, Ar), 7.80 (d, 1H, J = 8.2 Hz, Ar), 7.69 (d, 1H, J = 9.0 Hz, Ar), 7.64 (d, 1H, J = 9.0 Hz, Ar), 7.62 (d, 1H, J = 8.9 Hz, Ar), 7.48 (m, 1H, Ar), 7.48–7.42 (m, 1H, Ar), 7.39–7.35 (m, 2H, Ar), 7.32–7.25 (m, 5H, Ar), 7.25–7.18 (m, 3H, Ar), 7.17–7.07 (m, 6H, Ar), 7.02–6.97 (m, 3H, Ar), 6.91–6.87 (m, 2H, Ar), 6.84–6.78 (m, 6H, Ar), 6.67 (d, 2H, J = 7.6 Hz, Ar), 6.64 (d, 1H, J = 8.9 Hz, Ar), 6.45 (d, 1H, J = 7.6 Hz, Ar), 6.28 (d, 1H, J = 9.0 Hz, Ar), 5.39 (s, 1H, NH), 5.18 (s, 1H, NH), 4.33 (m, 2H, CHCH3), 0.95 (d, 6H, J = 7.2 Hz, CH3) ppm. 13C{1H}-NMR (150 MHz, CDCl3): δ = 150.84 (d, J = 8.6 Hz, Cq), 150.30 (d, J = 1.8 Hz, Cq), 142.98 (2Cq), 142.57 (Cq), 142.24 (Cq), 140.86 (Cq), 139.78 (Cq), 134.35 (Cq), 134.18 (Cq), 133.47 (Cq), 133.42 (Cq), 130.97 (Cq), 130.25 (CH), 129.97 (Cq), 129.47 (Cq), 129.38 (CH), 129.28 (Cq), 129.05 (2CH), 129.01 (CH), 128.96 (2CH), 128.82 (CH), 128.41 (4CH), 128.40 (CH), 128.08 (CH), 127.99 (CH), 127.87 (5CH), 126.96 (CH), 126.85 (CH), 126.81 (2CH), 126.53 (CH), 126.28 (CH), 125.37 (CH), 125.35 (CH), 125.10 (CH), 125.08 (CH), 124.96 (CH), 124.35 (CH), 123.14 (CH), 123.13 (CH), 122.83 (d, J = 3.5 Hz, Cq), 122.74 (d, J = 5.7 Hz, CH), 121.84 (2CH), 120.32 (2CH), 120.27 (d, J = 2.0 Hz, Cq), 120.07 (2CH), 119.50 (d, J = 20.5 Hz, CH), 117.79 (Cq), 117.64 (CH), 117.42 (CH), 117.41 (Cq), 52.25 (CHCH3), 52.17 (CHCH3), 20.84 (2CHCH3) ppm. 31P{1H}-NMR (243 MHz, CDCl3): δ = 141.37. HRMS (ESI): m/z = calcd for C68H54N3O2P: 975.39482; found: 975.39497 [α]20D = −110° (c = 0.1, CH2Cl2).
Footnote |
| † Electronic supplementary information (ESI) available. See DOI: 10.1039/c2cy20657a |
| This journal is © The Royal Society of Chemistry 2013 |